Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials.

Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials.
复制标题

DOI:
10.1016/j.biocel.2013.06.024
复制
发表时间:
2013-10
影响因子:
4
通讯作者:
Leeuwenburgh, Christiaan
Leeuwenburgh, Christiaan
中科院分区:
生物学2区
文献类型:
--
作者:
Marzetti, Emanuele;Calvani, Riccardo;Cesari, Matteo;Buford, Thomas W.;Lorenzi, Maria;Behnke, Bradley J.;Leeuwenburgh, Christiaan

文献摘要

参考文献

被引文献

相似文献

Sarcopenia, the age-related loss of muscle mass and function, imposes a dramatic burden on individuals and society. The development of preventive and therapeutic strategies against sarcopenia is therefore perceived as an urgent need by health professionals and has instigated intensive research on the pathophysiology of this syndrome. The pathogenesis of sarcopenia is multifaceted and encompasses lifestyle habits, systemic factors (e.g., chronic inflammation and hormonal alterations), local environment perturbations (e.g., vascular dysfunction), and intramuscular specific processes. In this scenario, derangements in skeletal myocyte mitochondrial function are recognized as major factors contributing to the age-dependent muscle degeneration. In this review, we summarize prominent findings and controversial issues on the contribution of specific mitochondrial processes – including oxidative stress, quality control mechanisms and apoptotic signaling – on the development of sarcopenia. Extramuscular alterations accompanying the aging process with a potential impact on myocyte mitochondrial function are also discussed. We conclude with presenting methodological and safety considerations for the design of clinical trials targeting mitochondrial dysfunction to treat sarcopenia. Special emphasis is placed on the importance of monitoring the effects of an intervention on muscle mitochondrial function and identifying the optimal target population for the trial.
在肌肉减少症中设计II期B试验:最佳目标人群。
DOI: 10.1007/s12603-011-0058-9
发表时间: 2011-08
影响因子: 5.8
作者:
Pahor, M.;Cesari, M.
通讯作者: Cesari, M.
DOI: 10.1152/ajpcell.00031.2005
发表时间: 2005-10-01
影响因子: 5.5
作者:
Adhihetty, PJ;Ljubicic, V;Hood, DA
通讯作者: Hood, DA
DOI: 10.1016/j.biocel.2012.07.006
发表时间: 2013-01-01
影响因子: 4
作者:
Bhatia-Kissova, Ingrid;Camougrand, Nadine
通讯作者: Camougrand, Nadine
DOI: 10.2337/diabetes.54.9.2685
发表时间: 2005-09-01
期刊: DIABETES
影响因子: 7.7
作者:
Bach, D;Naon, D;Zorzano, A
通讯作者: Zorzano, A
DOI: 10.1007/s11357-010-9196-y
发表时间: 2011-06-01
期刊: AGE
影响因子: --
作者:
Carter, Christy S.;Giovaninni, Silvia;Marzetti, Emanuele
通讯作者: Marzetti, Emanuele